Effects of morphine during Mycobacterium tuberculosis H37Rv infection in mice

Life Sciences
Raman Preet SinghPrati Pal Singh

Abstract

The effects of opiates in various infections are well known; however, very little is known about tuberculosis infection. Therefore, in the present study, we report for the first time, the effects of morphine during murine tuberculosis. Mice were infected intravenously with Mycobacterium tuberculosis H37Rv, administered morphine (0.1-100 mg/kg subcutaneously on day 0 and day +15) and sacrificed on day +30 for CFU enumeration in lungs and spleen. Morphine exerted maximum suppression of infection at 5 mg/kg, and sometimes completes elimination of infection; naloxone, silica and aminoguanidine blocked the protective effect of morphine. In vitro, morphine lacked direct antimycobacterial activity up to 1x10(-4) M concentration, as assessed by radiometric BACTEC method. In macrophage model of infection, morphine showed maximal killing at 1x10(-7) M concentration, the activity was blocked by naloxone and aminoguanidine. These observations suggest that morphine exerts a dose-dependent effect in murine tuberculosis, the protective effect being naloxone-reversible and may involve macrophage-mediated protective mechanisms. These results may be helpful in developing new opioid-like chemical entities against tuberculosis infection.

References

Aug 1, 1966·The Journal of Experimental Medicine·A C AllisonM Birbeck
Oct 1, 1983·The Journal of Infectious Diseases·E TubaroC Santiangeli
Dec 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R R MacGregorA L Graziani
Apr 1, 1994·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·M V ReddyP R Gangadharam
Sep 1, 1995·International Journal of Immunopharmacology·R PacificiD Pietraforte
Jun 4, 1998·Journal of Neuroimmunology·J M RisdahlT W Molitor
Jun 4, 1998·Journal of Neuroimmunology·B M SharpJ M Bidlack
Oct 16, 2002·Annals of the Rheumatic Diseases·S H E Kaufmann
Jan 27, 2004·Journal of Neuroimmunology·Burt M Sharp
Sep 10, 2004·American Journal of Therapeutics·Ricardo VallejoRamsun Benyamin
Nov 16, 2004·Annals of the New York Academy of Sciences·T MamiyaM Ukai

❮ Previous
Next ❯

Citations

Jul 27, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Sabita RoyRoderick A Barke
Sep 1, 2009·Indian Journal of Microbiology·Raman Preet SinghPrati Pal Singh
Oct 17, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Travis Yamanaka, Ruxana T Sadikot
Nov 20, 2009·Scandinavian Journal of Infectious Diseases·Sarbjit Singh Jhamb, Prati Pal Singh
Oct 2, 2009·Peptides·Richard J Bodnar
Jan 11, 2020·Frontiers in Immunology·Toby K Eisenstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.